Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neuroone Medical Technologies Corp (NMTC)

Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,332
  • Shares Outstanding, K 30,863
  • Annual Sales, $ 3,450 K
  • Annual Income, $ -12,320 K
  • EBIT $ -7 M
  • EBITDA $ -6 M
  • 60-Month Beta 0.48
  • Price/Sales 9.12
  • Price/Cash Flow N/A
  • Price/Book 10.72

Options Overview Details

View History
  • Implied Volatility 329.51% ( +33.79%)
  • Historical Volatility 80.12%
  • IV Percentile 79%
  • IV Rank 35.23%
  • IV High 861.29% on 01/15/25
  • IV Low 40.20% on 02/18/25
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 899
  • Open Int (30-Day) 939

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8600 +25.58%
on 03/10/25
1.2500 -13.60%
on 02/18/25
-0.1200 (-10.00%)
since 02/14/25
3-Month
0.6800 +58.82%
on 12/17/24
1.3900 -22.30%
on 01/24/25
+0.3198 (+42.07%)
since 12/13/24
52-Week
0.5510 +96.01%
on 12/05/24
1.5000 -28.00%
on 03/26/24
+0.0100 (+0.93%)
since 03/14/24

Most Recent Stories

More News
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NMTC : 1.0800 (+5.88%)
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NMTC : 1.0800 (+5.88%)
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NMTC : 1.0800 (+5.88%)
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NMTC : 1.0800 (+5.88%)
NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NMTC : 1.0800 (+5.88%)
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

NMTC : 1.0800 (+5.88%)
NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

NMTC : 1.0800 (+5.88%)
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NMTC : 1.0800 (+5.88%)
NeuroOne Medical Technologies Reports $3 Million Payment from Zimmer Biomet as Part of Exclusive Distribution Agreement, Anticipates Significant Revenue Growth for Fiscal Year 2025

NeuroOne expands partnership with Zimmer Biomet, receiving a $3 million upfront payment, anticipating significant revenue growth and margin expansion.Quiver AI SummaryNeuroOne Medical Technologies Corporation...

NMTC : 1.0800 (+5.88%)
NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NMTC : 1.0800 (+5.88%)

Business Summary

NeuroOne Medical Technologies Corporation is a medical technology company. It focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne Medical Technologies Corporation is based in EDEN PRAIRIE, Minn.

See More

Key Turning Points

3rd Resistance Point 1.1891
2nd Resistance Point 1.1394
1st Resistance Point 1.1097
Last Price 1.0800
1st Support Level 1.0303
2nd Support Level 0.9806
3rd Support Level 0.9509

See More

52-Week High 1.5000
Fibonacci 61.8% 1.1375
Last Price 1.0800
Fibonacci 50% 1.0255
Fibonacci 38.2% 0.9135
52-Week Low 0.5510

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar